340 filings
6-K
EVGN
Evogene Ltd
2 Apr 24
Current report (foreign)
7:00am
EFFECT
EVGN
Evogene Ltd
29 Mar 24
Notice of effectiveness
12:15am
424B5
EVGN
Evogene Ltd
28 Mar 24
Prospectus supplement for primary offering
5:00pm
6-K
EVGN
Evogene Ltd
28 Mar 24
Current report (foreign)
4:45pm
20-F
2023 FY
EVGN
Evogene Ltd
Annual report (foreign)
28 Mar 24
9:16am
6-K
rtk0z3dh
20 Mar 24
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
9:00am
6-K
pc3dza2aa6s35dnx
7 Mar 24
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
7:00am
F-3
vl8ap4
1 Mar 24
Shelf registration (foreign)
7:03am
6-K
eue4plx7vx
22 Feb 24
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan
7:00am
6-K
3wkf d8n1
21 Feb 24
AgPlenus Announces Licensing & Collaboration Agreement with Bayer
7:01am
SC 13G
f5xtyvm0 al
14 Feb 24
Evogene / SILVERARC CAPITAL MANAGEMENT ownership change
8:30pm
6-K
vfaojurpao7z7avugf1
17 Jan 24
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
7:00am
6-K
lldqpvxbh18pu9
9 Jan 24
Current report (foreign)
8:30am
6-K
cvenr
19 Dec 23
Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation
7:00am
6-K
hy1 pvhxu9p
15 Nov 23
Evogene Reports Third Quarter 2023 Financial Results
7:00am
6-K
yj9ce
8 Nov 23
Lavie Bio Reports Advancement in Bio-Fungicide Program Against Downy
7:00am
6-K
974rcn0qev1lynkvlzd
21 Sep 23
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
7:00am
6-K
4a0qledah qsno6
19 Sep 23
Company Presentation Eyal Ronen, CEO September 2023
7:15am
6-K
9d4qjpp
13 Sep 23
Current report (foreign)
7:00am
6-K
r8i77
23 Aug 23
Current report (foreign)
7:00am